Ownership and insider activity for Lucid Diagnostics Inc. (LUCD): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma.
Price
| Price | $0.78 |
| Market Cap | $149M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-05-20 | Matheis Dennis | P-Purchase | 245,000 | $245K |
| 2026-03-23 | Lee Victoria Tou-ho | 100,000 | $125K | |
| 2026-03-23 | Lee Victoria Tou-ho | |||
| 2026-02-20 | Aklog Lishan | A-Award | 2,170,000 | |
| 2026-02-20 | Matheis Dennis | A-Award | 123,000 | |
| 2026-02-20 | White Debra | A-Award | 123,000 | |
| 2026-02-20 | Sparks Ronald M | A-Award | 123,000 | |
| 2026-02-20 | SOKOLOV JACQUE J | A-Award | 123,000 | |
| 2026-02-20 | PALUMBO JOHN R | A-Award | 123,000 | |
| 2026-02-20 | Lapidus Stanley | A-Award | 123,000 |
Balance Sheet (10y)
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17800 | $156404 | $111000 | $53.7M | $22.5M | $18.9M | $22.4M | $34.7M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | $200000 | $17000 | $45000 | $405000 | $643000 |
| Inventory | 0 | 0 | $834000 | $493000 | $111000 | $278000 | $341000 | $353000 |
| Total Current Assets | $17800 | $390900 | $1.4M | $57.3M | $24.4M | $22.1M | $25.1M | $37.5M |
| Property, Plant & Equipment | 0 | 0 | 0 | $971000 | $3.6M | $2.6M | $3.7M | $2.6M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | $3.4M | $1.4M | $736000 | $315000 |
| Total Assets | $17800 | $1.0M | $2.2M | $59.0M | $32.5M | $27.3M | $30.7M | $40.4M |
| Accounts Payable | $497225 | $799075 | $2.1M | $1.5M | $1.1M | $1.1M | $1.2M | $970000 |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 | $13.9M | $18.6M | $24.0M |
| Total Current Liabilities | $1.1M | $6.3M | $15.7M | $4.3M | $8.4M | $29.4M | $23.5M | $28.6M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $1.1M | $6.3M | $15.7M | $4.3M | $9.5M | $29.6M | $25.3M | $29.5M |
| Retained Earnings | -$1.1M | -$5.5M | -$13.8M | -$41.9M | -$98.1M | -$150.7M | -$203.8M | -$274.3M |
| Total Equity | -$1.1M | -$5.3M | -$13.5M | $54.7M | $23.0M | -$2.3M | $5.4M | $10.9M |
| Total Debt | 0 | 0 | 0 | 0 | $2.0M | $15.3M | $21.3M | $25.8M |
| Net Debt | -$17800 | -$156404 | -$111000 | -$53.7M | -$20.5M | -$3.6M | -$1.1M | -$8.9M |
| Working Capital | -$1.1M | -$6.0M | -$14.3M | $53.0M | $15.9M | -$7.3M | $1.6M | $8.9M |
Financial Health
| Debt / Equity | 2.28 |
| Current Ratio | 1.33 |
Profitability
| Return on Equity | -404.34% |
| Return on Invested Capital | -141.44% |
| Return on Assets | -134.18% |
| Gross Margin | -25.79% |
| Operating Margin | -930.85% |
| Net Margin | -959.76% |
Related companies: APYX · AVR · IRD · IXHL · OWLT · RCEL · RPID
Explore sector: Healthcare · Medical - Devices
More sections of LUCD: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks